P. Vernazza

Discipline

Economies et finances (2) Sociologie (1) Psychologie (1) Démographie (1)

Type de document

Articles (37) Recensions (1)

Co-auteur

Date

Source

Mot-clé

cohorte (30) Treatment (27) Swiss (27) thérapie (26) Therapeutics (26) Human beings (26) Patients (22) Patients (22) virus (20) adulte (20) adulte (20) Methods (19) Methods (19) infection (16) Immunodeficiency (16) Infection (16) Use (16) art (15) Art (15) Art (15) Art (15) Older people (15) art (15) temps (durée) (14) Ci (Chinese poetry) (14) Time (14) Confidence (14) risque (13) association (13) analyse (13)

Documents écrit par P. Vernazza (37) | parle de P. Vernazza (0)

Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
F. Hovaguimian et al.
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
K. Kusejko et al.
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.
C. Wan et al. (2 nov. 2020)
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
D. Sculier et al.
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.
L.A. Carlisle et al. (31 oct. 2020)
Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity.
J.A. Roth et al.
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
Y. Ruffieux et al.
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
Adverse events of raltegravir and dolutegravir.
L. Elzi et al. (24 août 2017)
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
A. Gueler et al. (28 janv. 2017)
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.
L. Salazar-Vizcaya et al.
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
W.L. Yang et al. (2015)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
F. Bihl et al. (2015)
Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population.
B. Hasse et al. (2015)
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.
W.L. Yang et al. (2015)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.
I. Bartha et al. (2013)
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients.
N. Beerenwinkel et al. (2013)
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study.
A. van Sighem et al. (2012)
Ageing with HIV: medication use and risk for potential drug-drug interactions.
C. Marzolini et al. (2011)
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
R. Lubomirov et al. (2011)
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
M. Ortiz et al. (2011)
Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
V. Von Wyl et al. (2011)

next